PSMA and 18F-FDG PET Imaging in the Treatment of Metastatic Prostate Cancer with 223Ra: Initial Application and Experience
Objective To share our experience of the use of prostate specific membrane antigen (PSMA) and/or 18F-fluoroodexyglucose (18F-FDG) positron emission tomography (PET) in the setting of radium-223 dichloride (223Ra) in treatment of bone metastases of prostate cancer in order to broaden the know-ledge...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Chinês |
| Foilsithe / Cruthaithe: |
Editorial Office of Medical Journal of Peking Union Medical College Hospital
2023-07-01
|
| Sraith: | Xiehe Yixue Zazhi |
| Ábhair: | |
| Rochtain ar líne: | https://xhyxzz.pumch.cn/en/article/doi/10.12290/xhyxzz.2023-0152 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|